15 days ago
PRAX
AnalystsDavid HoangDavid Hoang's Stock Forecasts
AnalystsDavid Hoang
Sectors:
Analyst Ranking
Top 17%
#843 out of 5084 analysts
Average Return
+10.04%
Win Rate
55%22 out of 40
Risk vs Reward
Poor
Good
David Hoang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +181.99% | $21.27 | $59.98 | 2024-02-16 - 2024-11-29 | Strong Buy |
Praxis Precision Medicines IncPRAX | +138.60% | $84.24 | $201.00 | 2025-02-11 - 2025-10-30 | Strong Buy |
Avadel Pharmaceuticals PLCAVDL | +109.22% | $9.00 | $18.83 | 2025-02-11 - 2025-10-30 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +95.12% | $30.74 | $59.98 | 2024-07-02 - 2024-11-29 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +82.59% | $32.85 | $59.98 | 2024-08-02 - 2024-11-29 | Strong Buy |
David Hoang Analyst Color
Get additional color on David Hoang's coverage of popular stocks
4 months ago
HRMY
7 months ago
ALKS
a year ago
SRPT
David Hoang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $280.00 | +39.30% | Maintains | 15 days ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $43.00 | +77.25% | Initiates Coverage On | a month ago |
Harmony Biosciences Holdings IncHRMY | 4 | Strong Buy | $36.00 | +24.57% | Maintains | a month ago |
Sarepta Therapeutics IncSRPT | 10 | Strong Sell | $12.00 | -48.39% | Maintains | 3 months ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $35.00 | +53.91% | Upgrades | 5 months ago |
Alkermes PLCALKS | 2 | Strong Buy | $52.00 | +68.72% | Maintains | 7 months ago |
Xenon Pharmaceuticals IncXENE | 3 | Strong Buy | $67.00 | +57.02% | Initiates Coverage On | 9 months ago |
Denali Therapeutics IncDNLI | 3 | Strong Buy | $31.00 | +89.26% | Initiates Coverage On | 9 months ago |
Biohaven LtdBHVN | 1 | Strong Buy | $65.00 | +273.78% | Initiates Coverage On | 9 months ago |
Axsome Therapeutics IncAXSM | 4 | Strong Buy | $176.00 | +32.18% | Initiates Coverage On | 9 months ago |
Avadel Pharmaceuticals PLCAVDL | 1 | Strong Buy | $12.00 | -36.27% | Initiates Coverage On | 9 months ago |
Neurocrine Biosciences IncNBIX | 4 | Hold | $158.00 | N/A | Maintains | a year ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $50.00 | N/A | Maintains | a year ago |
Acumen Pharmaceuticals IncABOS | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | a year ago |
Sage Therapeutics IncSAGE | 1 | Strong Sell | $8.00 | N/A | Initiates Coverage On | a year ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | $220.00 | N/A | Initiates Coverage On | 3 years ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Buy | $80.00 | N/A | Initiates Coverage On | 3 years ago |
Provention Bio IncPRVB | 1 | Hold | $25.00 | N/A | Downgrades | 3 years ago |
Gossamer Bio IncGOSS | 1 | Hold | $3.00 | N/A | Downgrades | 3 years ago |
Orchard Therapeutics PLCORTX | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.